Pharmafile Logo
Pharmafocus logo
Advanced Search

hep C

Showing 15 posts of 44 posts found.

abbvie_0

AbbVie sue NHS over hepatitis C drug procurement

November 8, 2018
Business Services AbbVie, NHS, britain, court, hep C, hepatitis, ruling

American pharma firm AbbVie are suing Britain’s NHS after claiming that the health service’s procurement of hepatitis C drugs breached …

News
UNITAID

Medicines Patent Pool to include hep C and TB drugs

November 9, 2015
Sales and Marketing Medicines Patent Pool, affordable drugs, hep C, hepatitis, hepatitis C, medicines access, tuberculosis

The Medicines Patent Pool has expanded to include a mandate to make treatments for hepatitis C and tuberculosis affordable and …

News
Sovaldi image

China rejects Gilead’s Sovaldi patent

June 24, 2015
Research and Development, Sales and Marketing China, Gilead, hep C, sofosbuvir, sovaldi

Manufacturer of the blockbuster hepatitis C treatment Sovaldi Gilead has seen its application for a patent in China rejected following …

News
Sovaldi image

$10 generic Solvaldi emerges in Bangladesh

March 10, 2015
Manufacturing and Production, Sales and Marketing Gilead, World Trade Organization, hep C, incepta, sofosbuvir, sofosbuvir), sovaldi

A Bangladeshi pharma company is producing an unlicensed generic version of Gilead’s hepatitis C drug Sovaldi for $10 per pill …

News
Sovaldi image

Gilead frustrated despite final NICE Sovaldi nod

February 25, 2015
Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, sofosbuvir, sovaldi

NICE has published final guidance confirming its approval of Gilead’s controversial blockbuster hepatitis C treatment Sovaldi – but Gilead and …

News
J&J image

Olysio and Xarelto boost J&J’s Q4

January 21, 2015
Sales and Marketing J&J, JJ, Janssen, NICE, Remicade, Velcade, Xarelto, financials, hep C, olysio, q4, quarter four

Johnson & Johnson earned a 10% increase in worldwide sales of its drugs in the last quarter of 2014 compared …

News
Viekirax and Exviera image

AbbVie Hep C combo pill ready for Europe

January 16, 2015
Medical Communications AbbVie, Exviera, FDA, HIV, Viekira Pak, Viekirax, harvoni, hep C, sovaldi

The European Commission has approved AbbVie’s Viekirax and Exviera for the treatment of chronic hepatitis C (HCV). Viekirax (ombitasvir/paritaprevir/ritonavir) and …

News
Olysio image

Janssen privy to new pricing scheme and see NICE nod

January 16, 2015
Sales and Marketing Janssen, NHS, NICE, hep C, hepatitis, olysio, ribavirin, simeprevir

Janssen’s hepatitis C drug Olysio has been approved by NICE whilst also reaching a novel ‘pay if you clear’ pricing …

News
Sovaldi image

NICE approves Sovaldi

January 16, 2015
Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, pharma, sofosbuvir, sovaldi

NICE has recommended Sovaldi in final draft guidance and extended its scope, despite concerns over the price of the blockbuster …

News
Sovaldi image

Gilead sued over Sovaldi price

December 15, 2014
Sales and Marketing BMS, Gilead, NICE, harvoni, hep C, septa, sofosbuvir, sovaldi

A payer is suing Gilead over the price of its hep-c drug Sovaldi in the US after spending $2.4 million …

News
BMS image

BMS claims advance with hepatitis C regimen

November 10, 2014
Research and Development, Sales and Marketing BMS, Gilead, HCV, dcv-trio, hep C, hepatitis C, liver, sovaldi

Bristol-Myers Squibb has reported data for its hepatitis C virus cocktail that it says outperforms even newer all-oral therapies in …

News
Sovaldi image

Sovaldi misses estimates but still makes history

October 29, 2014
Research and Development, Sales and Marketing FDA, Gilead, harvoni, hep C, sofosbuvir, sovaldi

The trajectory of Gilead’s new hep C pill Sovaldi has slowed but the drug is still on course to break …

News
Merck image

Merck revenue falls

October 28, 2014
Manufacturing and Production, Sales and Marketing Frazier, Merck, Q3, Victrelis, hep C, sovaldi

Merck has posted a set of disappointing financials for the latest quarter as it cuts cost across its business to …

News
BMS image

BMS pulls hep C combo treatment in US

October 7, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Combo, HCV, asunaprevir, daclatasvir, hep C, sovaldi

Bristol-Myers Squibb will not attempt to bring its new combination hepatitis C treatment to the US market given the current …

News
Sovaldi pack shot

Sovaldi ‘unaffordable’ says NHS documents

October 7, 2014
Medical Communications, Research and Development, Sales and Marketing NHS England, fund, hep C, sovaldi

Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024